an oncology-focused precision medicine company committed to the discovery and development of targeted cancer therapeutics for patient populations selected using molecular diagnostics.
Industry Biotechnology
A.I.dvisor indicates that over the last year, IDYA has been loosely correlated with GRI. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if IDYA jumps, then GRI could also see price increases.
Ticker / NAME | Correlation To IDYA | 1D Price Change % | ||
---|---|---|---|---|
IDYA | 100% | -1.58% | ||
GRI - IDYA | 54% Loosely correlated | +3.51% | ||
INAB - IDYA | 47% Loosely correlated | -9.49% | ||
PLRX - IDYA | 46% Loosely correlated | -0.36% | ||
ABSI - IDYA | 44% Loosely correlated | -13.74% | ||
RCKT - IDYA | 44% Loosely correlated | -2.25% | ||
More |